SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : American Home Products AHP -- Ignore unavailable to you. Want to Upgrade?

To: TheSlowLane who wrote (111)9/3/1998 9:37:00 AM
From: Henry Niman  Respond to of 169
 
Three papers coming out in Sept issue of Nature-Medicine discuss Rezulin,
COX-2 Inhibitors, and Colon Cancer. All of the data is pre-clinical and results
are mixed, but they do raise some interesting questions concerning TZDs and
COX-2 inhibitors. Details linked to the COX-2 table at
home.att.net



To: TheSlowLane who wrote (111)9/9/1998 6:32:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 169
 
The Nature Medicine articles on Rezulin, COX-2 Inhibitors and Colon Cancer are now out. Articles are linked to the TZD (Rezulin - Avandia) table at http://biocognizance/diab.htm
or the COX-2 table at http://biocognizance/ther.html


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News